First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

por Yin, Xue-Ru, Liu, Zhi-Hong, Liu, Jing, Liu, Yuan-Yuan, Xie, Li, Tao, Li-Bo, Jia, Ji-Dong, Cui, Fu-Qiang, Zhuang, Gui-Hua, Hou, Jin-Lin
Publicado 2019